COO, CFO and Secretary
Tue, Aug 15, 2023
Aug 15
exercised or converted securities in DAWN
1,375 shares @ $0.00
Decreased holdings by -10.00%
Net across this filing: +1.00% (+2,703 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology